Medicine and Dentistry
Cytotoxicity
100%
Cell Death
100%
Lung Cancer Cell Line
100%
Non Small Cell Lung Cancer
100%
Reactive Oxygen Species
83%
Cancer Cell
50%
DNA Degradation
50%
Lung Cancer
33%
Cell Cycle Checkpoint
33%
Caspase
33%
Cell Viability
33%
Propidium Iodide
33%
Cell Cycle Arrest
33%
N-Acetylcysteine
33%
In Vitro
16%
Cell Cycle
16%
Cell Line
16%
Health Care Cost
16%
Antioxidant
16%
Mitochondrial DNA
16%
Cancer Cell Line
16%
Cell DNA
16%
Lipocortin 5
16%
Fluorescence Activated Cell Sorting
16%
Caspase Inhibitor
16%
MTT Assay
16%
Active Immunotherapy
16%
Leukocyte Extract
16%
Transfer Factor
16%
Radiation Therapy
16%
Side Effect
16%
Keyphrases
Cytotoxic Activity
100%
Human Lung Cancer Cell Line
100%
IMMUNEPOTENT CRP
100%
Cell Death
50%
Reactive Oxygen Species Production
37%
DNA Degradation
37%
Reactive Oxygen Species
25%
Cell Cycle Arrest
25%
Caspase
25%
Cytotoxicity
25%
N-acetylcysteine
25%
Mitochondrial Damage
25%
Cell Viability
25%
Lung Cancer Cells
25%
Propidium Iodide Staining
25%
Mechanism of Action
12%
Cell-to-cell
12%
Antioxidant
12%
Cancer Cell Lines
12%
Radiotherapy
12%
In Vitro Activity
12%
Mitochondrial Alterations
12%
A549
12%
Induced Cell Death
12%
Fluorescence-activated Cell Sorting
12%
Non-small Cell Lung Cancer (NSCLC)
12%
Non-small Cell Lung Cancer Cells
12%
Annexin V
12%
Lung Cancer Cell Lines
12%
Pre-treating
12%
MTT Assay
12%
Cytotoxic Mechanism
12%
Active Immunization
12%
Pan-caspase Inhibitor
12%
Transfer Factor
12%
Death Cell
12%
DNA Mitochondrial
12%
Chemotherapy Side Effects
12%
Regulated Cell Death
12%
Dialyzable Leukocyte Extract
12%
Cycle Degradation
12%
Lung Cancer A549 Cells
12%
DCFDA
12%
Species Dependence
12%
Immunology and Microbiology
Cell Death
100%
Cytotoxicity
100%
Lung Cancer Cell Line
100%
Cancer Cell
50%
Caspase
50%
DNA Degradation
50%
Cell Cycle Checkpoint
33%
Cell Viability
33%
Propidium Iodide
33%
Cell Cycle Arrest
33%
Cell Line
16%
Cell Cycle
16%
Cancer Cell Line
16%
Fluorescence Activated Cell Sorting
16%
Transfer Factor
16%
Active Immunotherapy
16%
Leukocyte Extract
16%
In Vitro
16%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Cytotoxicity
100%
Reactive Oxygen Metabolite
83%
Lung Cancer
50%
Caspase
33%
Cell Viability
33%
Propidium Iodide
33%
N-Acetylcysteine
33%
Malignant Neoplasm
16%
Chemotherapy
16%
Antioxidant
16%
Immunotherapy
16%
Caspase Inhibitor
16%
Lipocortin 5
16%
Fluorescence Activated Cell Sorting
16%
Leukocyte Extract
16%
Transfer Factor
16%
Side Effect
16%